Accelerating developments in heart failure.

Heart failure remains a leading cause of morbidity and mortality globally. Within the last 5 years, many new developments have been seen in the area of heart failure, including completely new therapies, mechanistic insights, as well as novel strategies to phenotype and segment the condition. Borlaug I et al i .[1] focus on the emerging problem of obesity and heart failure with preserved ejection fraction (HFpEF), which represents indeed one of the greatest unmet health problems in the field of cardiovascular medicine in the 21st century. [Extracted from the article]